approval
saveVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalCARIPRAZINE HYDROCHLORIDE — FDA approvalDec 16, 2025 · 292d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalNov 22, 2024 · 681d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 16, 2022 · 1388d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalMay 24, 2019 · 2690d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalNov 28, 2018 · 2867d ago
same company · ±60 days · 6
- approvalCARIPRAZINE HYDROCHLORIDE: VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025
- approvalCARIPRAZINE HYDROCHLORIDE: VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025
- approvalCARIPRAZINE HYDROCHLORIDE: VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025
- approvalORIAHNN (COPACKAGED): ORIAHNN (COPACKAGED) (ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE) — FDA approvalDec 17, 2025
- approvalelagolix sodium: ORILISSA (ELAGOLIX SODIUM) — FDA approvalDec 17, 2025
- approvaladalimumab: HUMIRA (ADALIMUMAB) — FDA approvalDec 23, 2025
comments(0)
5-min edit window · permanent after that